Courses List

0
No products in the cart.
← Literature Database

Influence of acetylsalicylic acid and low-molecular weight heparins on the formation of renal hematoma after shock wave lithotripsy.

Practice Point

Christoph Schregel, Hubert John, Marco Randazzo, Isabelle Keller

World journal of urology · 2017 · Vol. 35 · Issue 12 · 1939-1946

PMID: 28702844 DOI: 10.1007/s00345-017-2070-0

Academy Summary

Schregel and colleagues investigated whether acetylsalicylic acid (aspirin/ASA) and low-molecular-weight heparin (LMWH) increase the risk of renal haematoma following shock wave lithotripsy.

This retrospective cohort included 434 patients treated with SWL for renal stones or proximal ureteral stones. All patients underwent ultrasound examination on the first day after treatment specifically to detect renal haematoma. Thirty-day outcomes included bleeding-related intervention, blood transfusion, hospital readmission, and death. (pubmed.ncbi.nlm.nih.gov)

Of the 434 patients:

  • 33 patients, 7.6%, were receiving ASA.
  • 67 patients, 15.4%, were receiving LMWH.
  • Renal haematoma was detected in 20 patients, 4.6%.

On univariate analysis, renal haematoma was significantly associated with ASA use, LMWH use, untreated urinary tract infection, and a history of cardiovascular disease.

After multivariable analysis, ASA medication, untreated UTI, and therapeutic-dose LMWH remained independent predictors of renal haematoma. Therapeutic-dose LMWH demonstrated the strongest association, with a reported odds ratio of approximately 10.4. (pubmed.ncbi.nlm.nih.gov)

The study therefore reinforces that renal bleeding after SWL is influenced not only by antithrombotic medication but also by potentially modifiable clinical factors such as untreated urinary infection.

Unlock the Academy Interpretation for Free

Create a free Lithotripsy Academy account or log in to access the complete Academy interpretation, including Key Findings, Clinical Takeaway, Limitations, and Expert Commentary

Subscribe to View Details Already a member? Log in
Comments & Discussion0 comments

Discuss the publication's evidence, limitations and practical relevance. Please do not include identifiable patient information or individual medical advice.

No comments yet. Start the discussion.